GlassScriptPhysician profile
Melodi Esmaili
NPI 1962819938
$3,943.93
in general payments reported to CMS, 2019-2025
21 companies · $481 in 2025
The $481 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $140 · 2021: $409 · 2022: $910 · 2023: $595 · 2024: $660 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,739.81 | 2019-2025 | |
| Coopervision INC. | $423.17 | 2019-2025 | Paragon Crt, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $225.73 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $214.44 | 2022-2025 | Infuse, Miebo |
| Alcon Vision LLC | $188.54 | 2019-2025 | Tryptyr |
| Novartis Pharmaceuticals Corporation | $144.29 | 2021-2022 | |
| Optos, INC. | $142.16 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $141.23 | 2021-2022 | |
| Glaukos Corporation | $131.43 | 2019-2022 | |
| Shire North American Group INC | $119.03 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $109.40 | 2024-2025 | Xdemvy |
| E.R. Squibb & Sons, L.L.C. | $67.76 | 2023 | |
| Abbvie INC. | $53.88 | 2022-2023 | |
| Allergan, INC. | $52.39 | 2021-2022 | |
| Amgen INC. | $49.42 | 2025 | Uplizna |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $41.26 | 2022-2025 | Tyrvaya |
| Rxsight INC | $25.67 | 2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Visioneering Technologies, INC. | $21.56 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $18.83 | 2022 | |
| Dompe US, INC. | $17.34 | 2021 | |
| Lombart Brothers, INC. | $16.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melodi Esmaili listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.